Study of Eyes and Attention Deficit (SEAD)

This study has been completed.
Sponsor:
Information provided by:
Ohio State University
ClinicalTrials.gov Identifier:
NCT00472511
First received: May 9, 2007
Last updated: July 1, 2008
Last verified: July 2008
  Purpose

Attention-Deficit Hyperactivity Disorder (ADHD) is considered to be one of the most prevalent chronic health conditions in children. It affects between 4% and 12% of young children. A relationship between convergence insufficiency (eye teaming) and ADHD has been shown. However, the effect of ADHD medications on focusing and eye teaming has not been previously investigated. Therefore, the purpose of this study is to determine the effect of ADHD medication on focusing and eye teaming skills.


Condition
ADHD
Convergence Insufficiency
Accommodative Insufficiency

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Ohio State University:

Estimated Enrollment: 75
  Eligibility

Ages Eligible for Study:   7 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Best corrected visual acuity of 20/25 in both eyes at distance and near;
  • Willingness to wear eyeglasses or contact lenses to correct refractive error, if necessary;
  • 500" random dot stereopsis

Exclusion Criteria:

  • Amblyopia (lazy eye);
  • Eye disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00472511

Sponsors and Collaborators
Ohio State University
Investigators
Principal Investigator: Levelle Jenkins, OD Ohio State University
Principal Investigator: Marjean Kulp, OD, MS Ohio State University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00472511     History of Changes
Other Study ID Numbers: 2001H0269
Study First Received: May 9, 2007
Last Updated: July 1, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Ocular Motility Disorders
Central Nervous System Diseases
Nervous System Diseases
Cranial Nerve Diseases
Eye Diseases

ClinicalTrials.gov processed this record on July 29, 2014